まとめ
缺血性心筋の再注入は,非再入性および再入性メカニズムを通じて悪性心室不律を引き起こします. これらの心律乱は,心室動脈不全とをはじめ,心下内臓から発生し,複雑な電気活動によって維持されます.
科学分野:
- 心臓病学 心臓病学
- 電気生理学 電気生理学
- 心臓外科手術について
背景:
- 心筋動脈不全と再注血は,心律動乱症において重要な役割を果たします.
- 再注血後の心房不律症のメカニズムを理解することは,患者のアウトカムにとって不可欠です.
研究 の 目的:
- 心筋再注射中の悪性心室不律症のメカニズムを図解する.
- 室細動脈 (VT) と室細動脈 (VF) の発症および維持における再侵入および非再侵入メカニズムを区別する.
主な方法:
- コンピュータ化された3次元マッピングシステムを利用し,同時に8レベルのトランミュラル録音を行いました.
- 麻酔を受けた6匹の猫で10分間,再注射が続く,誘発された地域性缺血.
- 分析された心室活性化時間と心拍不全の開始/維持メカニズム.
主要な成果:
- 循環後15秒以内に心室性短拍 (VT) が発生し,一部では心室細動 (VF) に進行した.
- 持続不可能なVTの開始は,非再侵入メカニズム (75%) または,再侵入ゾーンの境界で内壁再侵入 (25%) 経由で発生しました.
- VTのメンテナンスには,非再入力および再入力メカニズムの両方が含まれ,非再入力活動と伝導遅延によってVFへの移行がもたらされた.
結論:
- リパーフュージョン誘発性心房不律症は,非再入電現象と再入電現象の複雑な相互作用を伴う.
- アリズム障害の発生と維持のメカニズムは異なるが,非再侵入経路が重要な役割を果たし,特にVFへの移行において重要な役割を果たしている.
- 副内臓の活性化と伝導の異常は,これらの生命を脅かす不律症の発生に重要な要因である.
関連する概念動画
Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias I: Introduction
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...


